20 June 2013
Keywords: Actavis, QRxPharma, MoxDuo, Pain drug, USA
Article | 21 December 2011
Iceland-headquartered generics major Actavis Group, via its US subsidiary, has entered into a binding letter of intent with Australian firm ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 December 2011
22 December 2011
19 June 2013
© 2013 thepharmaletter.com